Journal for ImmunoTherapy of Cancer
ISSN: 2051-1426
Publisher: BioMed Central
Publications (55)
IDENTIFICATION AND CHARACTERIZATION OF CIRCULAR RNAS AS NOVEL PUTATIVE BIOMARKERS TO PREDICT THE SURVIVAL BENEFIT AMONG METASTATIC MELANOMA PATIENTS TREATED WITH ANTI-PD-1 MONOTHERAPY (2022)
Zhou JG, Gaipl U, Ma H, Wang H
Conference contribution
Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors (2022)
Borchmann S, Selenz C, Lohmann M, Ludwig H, Gassa A, Braegelmann J, Lohneis P, et al.
Journal article
Automated, scaled, transposon-based production of CAR T cells (2022)
Lock D, Monjezi R, Brandes C, Bates S, Lennartz S, Teppert K, Gehrke L, et al.
Journal article
BISPECIFIC ANTIBODIES ENABLE SYNTHETIC AGONISTIC RECEPTOR T CELL THERAPY IN MELANOMA (2022)
Benmebarek M, Maerkl F, Keyl J, Cadilha B, Geiger M, Karches C, Obeck H, et al.
Conference contribution
UNDERSTANDING HOW EPITOPE BINDING INFLUENCES ANTIBODY DEPENDENT COMPLEMENT ENGAGEMENT FOR THERAPY OF B-CELL MALIGNANCIES (2022)
Bondza S, Buijs J, Lux A
Conference contribution
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside? (2022)
Guedan S, Luu M, Ammar D, Barbao P, Bonini C, Bousso P, Buchholz CJ, et al.
Journal article, Review article
Time to evolve: predicting engineered T cell-associated toxicity with next-generation models (2022)
Donnadieu E, Luu M, Alb M, Anliker B, Arcangeli S, Bonini C, De Angelis B, et al.
Journal article, Review article
Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activation (2022)
Sorrentino A, Menevse AN, Michels T, Volpin V, Durst FC, Sax J, Xydia M, et al.
Journal article
Immune cell infiltration pattern in non-small cell lung cancer PDX models is a model immanent feature and correlates with a distinct molecular and phenotypic make-up (2022)
Oswald E, Bug D, Grote A, Lashuk K, Bouteldja N, Lenhard D, Loehr A, et al.
Journal article
Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer (2022)
Busenhart P, Montalban-Arques A, Katkeviciute E, Morsy Y, Van Passen C, Hering L, Atrott K, et al.
Journal article